Karyopharm Therapeutics (KPTI) Liabilities and Shareholders Equity (2012 - 2026)
Karyopharm Therapeutics (KPTI) posted Liabilities and Shareholders Equity of $111.32 million for Q2 2026, up 6.1% from $104.88 million a year earlier.
Powered by 
Analysis
Karyopharm Therapeutics (KPTI) Liabilities and Shareholders Equity (2012 - 2026) Analysis & Trends
At the end of FY2025, Karyopharm Therapeutics' Liabilities and Shareholders Equity came in at $108.42 million, down 34.1% from FY2024.
- Annual Liabilities and Shareholders Equity has declined for three consecutive years, with a five-year compound annual growth rate of -19.1% (FY2020 to FY2025).
- In prior years, Karyopharm Therapeutics' Liabilities and Shareholders Equity was $164.42 million in FY2024 (-31.6%), $240.44 million in FY2023 (-32.9%), $358.17 million in FY2022 (+17.3%) and $305.31 million in FY2021 (-2.5%).
- The Q2 2026 figure stands as the highest quarterly Liabilities and Shareholders Equity since Q1 2025.
- On a year-over-year basis, Liabilities and Shareholders Equity increased in 1 of the last seven quarters, with an average decline of 32.4%.
- The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was Q4 2022, with growth of 17.3%; the weakest was Q2 2025, with a decline of 51.0%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,164.71 Bn | 1,133.30 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 633.37 Bn | 551.90 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 503.99 Bn | 477.10 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 378.19 Bn | 332.57 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 303.15 Bn | 267.14 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 266.17 Bn | 239.85 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 241.38 Bn | 196.78 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 194.07 Bn | 168.27 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 172.31 Bn | 118.96 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Karyopharm Therapeutics | 14.78 Mn | -211.64 Mn | 32.35 Mn | 111.32 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 111.32 Mn |
| Dec 31, 2025 | 108.42 Mn |
| Sep 30, 2025 | 96.23 Mn |
| Jun 30, 2025 | 104.88 Mn |
| Mar 31, 2025 | 127.71 Mn |
| Dec 31, 2024 | 164.42 Mn |
| Sep 30, 2024 | 189.48 Mn |
| Jun 30, 2024 | 213.98 Mn |
| Mar 31, 2024 | 204.46 Mn |
| Dec 31, 2023 | 240.44 Mn |
| Sep 30, 2023 | 269.96 Mn |
| Jun 30, 2023 | 297.83 Mn |
| Mar 31, 2023 | 325.80 Mn |
| Dec 31, 2022 | 358.17 Mn |
| Sep 30, 2022 | 231.24 Mn |
| Jun 30, 2022 | 256.48 Mn |
| Mar 31, 2022 | 294.03 Mn |
| Dec 31, 2021 | 305.31 Mn |
| Sep 30, 2021 | 254.09 Mn |
| Jun 30, 2021 | 286.57 Mn |
API Access
Karyopharm Therapeutics Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=KPTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "KPTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=KPTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();